Filtered By:
Therapy: Immunotherapy
This page shows you your search results in order of relevance. This is page number 7.
Order by Relevance | Date
Total 36235 results found since Jan 2013.
Hematological aspects of the COVID-19 syndrome
CONCLUSIONS: The final episode of this pandemic will include the "chimerism-mediated immunotherapy" that will eventually lead to end of the COVID-19 process. The recent Omicron variant seems to have unique evasion effects on the interferon gene expression which will boost the chimerism-mediated immunotherapy without high mortality rates.PMID:35776048 | DOI:10.26355/eurrev_202206_29086
Source: European Review for Medical and Pharmacological Sciences - July 1, 2022 Category: Drugs & Pharmacology Authors: U Y Malkan I C Haznedaroglu Source Type: research
A case of undifferentiated carcinoma of the bladder treated by combination therapy of surgery, local radiation, and immune checkpoint inhibitors
We present the case of an 81-year-old woman complaining of bladder irritation. Computed tomography (CT) and magnetic resonance imaging (MRI) revealed a bulky bladder tumor, which was diagnosed as cT4aN0M0. A transurethral resection of the bladder tumor revealed pT2 or higher urothelial carcinoma. The patient underwent total cystectomy with an ileal conduit diversion. Histological examination revealed a primary undifferentiated bladder carcinoma with a sarcoma component, pT3aN0M0. Postoperative adjuvant chemotherapy with gemcitabine plus carboplatin was administered. However, this regimen was discontinued after one course d...
Source: Nagoya Journal of Medical Science - December 22, 2022 Category: International Medicine & Public Health Authors: Wataru Nakane Yushi Naito Koya Morishita Kazuna Matsuo Shohei Ishida Yoshihisa Matsukawa Source Type: research
